News

In order to increase access to treatments that are recommended to fight COVID-19, the WHO has added a monoclonal antibody treatment called Tocilizumab to its list of prequalified options to treat the virus. Currently, the WHO has given a nod...

Collegium Pharmaceutical, Inc. and BioDelivery Sciences International, Inc. announced a definitive agreement pursuant to which Collegium will acquire BDSI for $5.60 per share in cash. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions....

ImmunityBio, Inc., a clinical-stage immunotherapy company announced the successful completion of its acquisition of the leasehold interest in an ISO Class 5 pharmaceutical manufacturing space in western New York from global pharmaceutical company Athenex, Inc. (NASDAQ: ATNX). The new state-of-the-art...

Tesis Biosciences, the leader in targeted genetic sequencing, has acquired Genome Explorations, a premier research institution providing global genomic profiling and molecular diagnostics services. The acquisition, which aligns with Tesis Biosciences' increased focus on clinical research and product development, will...

In a recent development, which is a kind of a setback in the case of inoculation for kids, the FDA has confirmed that it is going to delay authorising the use of the Pfizer vaccine in the younger lot...

Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for COVID-19. To date, six COVID-19 treatments have been prequalified by WHO, including the three presentations (three...

BioGenes has partnered with Alphalyse, a specialist contract research organization. Recently, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years have partnered up to offer their respective methods to biologics...